CF
LLY icon

Convergence Financial’s Eli Lilly LLY Stock Holding History

Convergence Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.01M Sell
4,360
-96
-2% -$97.3K 0.43% 44
2025
Q4 		$4.79M Buy
4,456
+58
+1% +$55.5K 0.7% 34
2025
Q3 		$3.36M Buy
4,398
+132
+3% +$98.2K 0.5% 38
2025
Q2 		$3.33M Buy
4,266
+291
+7% +$226K 0.57% 38
2025
Q1 		$3.28M Buy
3,975
+323
+9% +$269K 0.64% 34
2024
Q4 		$2.82M Buy
3,652
+56
+2% +$46.4K 0.56% 32
2024
Q3 		$3.19M Buy
3,596
+299
+9% +$269K 0.68% 30
2024
Q2 		$2.99M Buy
+3,297
New +$2.64M 0.79% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Convergence Financial's LLY Position: Q1 2026 in Review

Convergence Financial reduced its Eli Lilly (LLY) stake by 2.2% in Q1 2026, selling an estimated $97.3K and leaving 4,360 shares worth $4.01M. The position accounts for 0.43% of the portfolio, ranked #44.

Convergence Financial first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.79M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Convergence Financial held 4,360 shares of Eli Lilly worth $4.01M as of Q1 2026.
  • Convergence Financial sold 96 Eli Lilly shares in Q1 2026, an estimated $97.3K.
  • Eli Lilly made up 0.43% of Convergence Financial's portfolio in Q1 2026, its #44 holding.
  • Convergence Financial first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Convergence Financial's Eli Lilly position peaked at $4.79M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Convergence Financial's 13F filing for Q1 2026, filed 11 May 2026.